Eala, Michelle Ann B. http://orcid.org/0000-0002-5651-3513
Basilio, Patricia Anne S. http://orcid.org/0000-0001-8258-3809
Dee, Edward Christopher http://orcid.org/0000-0001-6119-0889
Cereno, Reno Eufemon P. http://orcid.org/0000-0001-8377-9707
Ang, Christian Daniel http://orcid.org/0000-0003-1510-9992
Magsanoc, Nikko J. http://orcid.org/0000-0003-0210-7090
Ting, Frederic Ivan L. http://orcid.org/0000-0002-9161-4918
Sacdalan, Dennis L. http://orcid.org/0000-0001-6617-9363
Article History
Received: 9 February 2022
Accepted: 22 June 2022
First Online: 20 July 2022
Declarations
:
: Dennis L. Sacdalan, MD has received honoraria from AstraZeneca, MSD Oncology, Zuellig Pharma, and Kalbe Farma. He has a consulting role at Unilab, Pfizer, and Roche. He is a member of the speakers' bureau for MSD, and Lilly. He has received support for travel, accommodations, and expenses from Unilab. Frederic Ivan L. Ting, MD has received honoraria from Pfizer and Axios International. He has a consulting role at Roche. All other authors declare no competing interests.